These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31316299)

  • 1. Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality.
    Valente MJ; Rocha S; Coimbra S; Catarino C; Rocha-Pereira P; Bronze-da-Rocha E; Oliveira JG; Madureira J; Fernandes JC; do Sameiro-Faria M; Miranda V; Belo L; Santos-Silva A
    Mediators Inflamm; 2019; 2019():3295725. PubMed ID: 31316299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis.
    Rocha S; Valente MJ; Coimbra S; Catarino C; Rocha-Pereira P; Oliveira JG; Madureira J; Fernandes JC; do Sameiro-Faria M; Miranda V; Belo L; Santos-Silva A; Bronze-da-Rocha E
    Sci Rep; 2021 Jul; 11(1):14768. PubMed ID: 34285273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Correlation Between Circulating Fetuin-A and Pentraxin-3 With Biochemical Parameters of Calcification in Hemodialysis Patients.
    Hashemi J; Joshaghani HR; Akaberi A; Hesari Z; Ghanbari R; Mohammadzadeh M; Golshan AR
    Arch Iran Med; 2017 Dec; 20(12):752-755. PubMed ID: 29664315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.
    Sjöberg B; Qureshi AR; Heimbürger O; Stenvinkel P; Lind L; Larsson A; Bárány P; Ärnlöv J
    J Intern Med; 2016 Feb; 279(2):173-9. PubMed ID: 26355706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.
    Oldani S; Finazzi S; Bottazzi B; Garlanda C; Baldassarre E; Valaperta S; Cuccovillo I; Albini M; Child M; Montanelli A; Graziani G; Badalamenti S
    J Nephrol; 2012; 25(1):120-6. PubMed ID: 21725917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease.
    Miyamoto T; Rashid Qureshi A; Heimbürger O; Bárány P; Carrero K; Sjöberg B; Lindholm B; Stenvinkel P; Carrero JJ
    Clin J Am Soc Nephrol; 2011 Dec; 6(12):2785-91. PubMed ID: 22157708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis.
    Yigit IP; Dogukan A; Taskapan H; Comert M; Ilhan N; Ulu R; Aygen B
    J Vasc Access; 2015; 16(5):377-81. PubMed ID: 26070095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
    Witasp A; Rydén M; Carrero JJ; Qureshi AR; Nordfors L; Näslund E; Hammarqvist F; Arefin S; Kublickiene K; Stenvinkel P
    PLoS One; 2013; 8(5):e63493. PubMed ID: 23658833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up.
    Zhou Y; Zhang J; Zhu M; Lu R; Wang Y; Ni Z
    Blood Purif; 2015; 39(4):266-73. PubMed ID: 25924996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study.
    Akdag I; Yilmaz Y; Kahvecioglu S; Bolca N; Ercan I; Ersoy A; Gullulu M
    Nephron Clin Pract; 2008; 108(2):c99-c105. PubMed ID: 18212491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria.
    Kasperska-Zajac A; Grzanka A; Misiolek M; Mazur B; Machura E
    Cytokine; 2015 Dec; 76(2):566-568. PubMed ID: 25982553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population.
    Baragetti A; Knoflach M; Cuccovillo I; Grigore L; Casula M; Garlaschelli K; Mantovani A; Wick G; Kiechl S; Willeit J; Bottazzi B; Catapano AL; Norata GD
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):518-23. PubMed ID: 24462365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
    Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
    Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than C-reactive protein.
    Zhou Y; Ni Z; Zhang J; Zhang W; Wu Q; Shen G; Wang Y; Qian J
    Vasc Med; 2013 Apr; 18(2):85-91. PubMed ID: 23609129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease.
    Boehme M; Kaehne F; Kuehne A; Bernhardt W; Schröder M; Pommer W; Fischer C; Becker H; Müller C; Schindler R
    Nephrol Dial Transplant; 2007 Aug; 22(8):2224-9. PubMed ID: 17496115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.
    Witasp A; Carrero JJ; Michaëlsson K; Ahlström H; Kullberg J; Adamsson V; Risérus U; Larsson A; Helmersson-Karlqvist J; Lind L; Stenvinkel P; Arnlöv J
    Obesity (Silver Spring); 2014 May; 22(5):1373-9. PubMed ID: 24415446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.
    Kahlow BS; Petisco R; Skare TL; Goeldner I; Nisihara RM; Messias-Reason IJ
    Int J Cardiol; 2016 Oct; 221():298-301. PubMed ID: 27404695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin 3 in Cardiovascular Disease.
    Ristagno G; Fumagalli F; Bottazzi B; Mantovani A; Olivari D; Novelli D; Latini R
    Front Immunol; 2019; 10():823. PubMed ID: 31057548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.